Net Loss Per Share Attributable to Common Stockholders (Tables)

3 Months Ended

Mar. 31, 2026

Earnings Per Share [Abstract]

Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share

The following common stock equivalents were excluded from the computation of diluted net loss per share as their impact would have been anti-dilutive:

	As of March 31,
	2026		2025
Common stock options issued and outstanding		12,064,129		40,134,786
Unvested RSU's of common stock		368,470		—
Redeemable convertible preferred stock on an as-converted into common stock basis		—		409,027,108
Shares issuable under the participation right		—		28,225,863
Total		12,432,599		477,387,757